Fig. 2. Apoptosis markers and cell cycle. Annexin V (early apoptotic) and annexin V-propidium iodide (PI; late apoptotic) positive cells after exposure to increasing concentrations (100, 250 μM) of ropivacaine for 24 h (A ). Cell cycle phases (G0/G1, S, G2/M) of mesenchymal stem cells exposed to 100 and 250 μM ropivacaine for 24 h indicative of cell cycle arrest (B ). Expression patterns of the G1phase regulatory proteins p16INK4a, p27Kip1, and proliferative cell nuclear antigen in whole cell lysates after exposure to increasing concentrations (100, 250 μM) of ropivacaine (C ). *Significantly different from CTL. #Significantly different from 100 μM. Data are mean (SD); n = 4 (A ) and n = 6 (B  and C ). CTL = control without treatment; PCNA = proliferative cell nuclear antigen; ROPI = ropivacaine.

Fig. 2. Apoptosis markers and cell cycle. Annexin V (early apoptotic) and annexin V-propidium iodide (PI; late apoptotic) positive cells after exposure to increasing concentrations (100, 250 μM) of ropivacaine for 24 h (A ). Cell cycle phases (G0/G1, S, G2/M) of mesenchymal stem cells exposed to 100 and 250 μM ropivacaine for 24 h indicative of cell cycle arrest (B ). Expression patterns of the G1phase regulatory proteins p16INK4a, p27Kip1, and proliferative cell nuclear antigen in whole cell lysates after exposure to increasing concentrations (100, 250 μM) of ropivacaine (C ). *Significantly different from CTL. #Significantly different from 100 μM. Data are mean (SD); n = 4 (A ) and n = 6 (B  and C ). CTL = control without treatment; PCNA = proliferative cell nuclear antigen; ROPI = ropivacaine.

Close Modal

or Create an Account

Close Modal
Close Modal